Logo image of TR1.DE

T ROWE PRICE GROUP INC (TR1.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:TR1 - US74144T1088 - Common Stock

86.84 EUR
+0.65 (+0.75%)
Last: 11/24/2025, 7:00:00 PM
Fundamental Rating

7

TR1 gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 120 industry peers in the Capital Markets industry. TR1 has an excellent financial health rating, but there are some minor concerns on its profitability. TR1 is valued quite cheap, while showing a decent growth score. This is a good combination! Finally TR1 also has an excellent dividend rating. These ratings could make TR1 a good candidate for value and dividend investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

TR1 had positive earnings in the past year.
In the past year TR1 had a positive cash flow from operations.
Each year in the past 5 years TR1 has been profitable.
TR1 had a positive operating cash flow in each of the past 5 years.
TR1.DE Yearly Net Income VS EBIT VS OCF VS FCFTR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

The Return On Assets of TR1 (13.79%) is better than 93.33% of its industry peers.
With a decent Return On Equity value of 18.78%, TR1 is doing good in the industry, outperforming 76.67% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 13.51%, TR1 belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for TR1 is significantly above the industry average of 9.33%.
Industry RankSector Rank
ROA 13.79%
ROE 18.78%
ROIC 13.51%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
TR1.DE Yearly ROA, ROE, ROICTR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of TR1 (28.18%) is better than 76.67% of its industry peers.
TR1's Profit Margin has declined in the last couple of years.
TR1 has a Operating Margin of 32.91%. This is in the better half of the industry: TR1 outperforms 75.83% of its industry peers.
TR1's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 32.91%
PM (TTM) 28.18%
GM N/A
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
TR1.DE Yearly Profit, Operating, Gross MarginsTR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The number of shares outstanding for TR1 has been reduced compared to 1 year ago.
Compared to 5 years ago, TR1 has less shares outstanding
Compared to 1 year ago, TR1 has an improved debt to assets ratio.
TR1.DE Yearly Shares OutstandingTR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TR1.DE Yearly Total Debt VS Total AssetsTR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 5.66 indicates that TR1 is not in any danger for bankruptcy at the moment.
TR1 has a Altman-Z score of 5.66. This is amongst the best in the industry. TR1 outperforms 91.67% of its industry peers.
TR1 has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
TR1 has a better Debt to FCF ratio (0.03) than 97.50% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that TR1 is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, TR1 belongs to the top of the industry, outperforming 88.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 5.66
ROIC/WACCN/A
WACCN/A
TR1.DE Yearly LT Debt VS Equity VS FCFTR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

TR1 has a Current Ratio of 2.76. This indicates that TR1 is financially healthy and has no problem in meeting its short term obligations.
TR1 has a better Current ratio (2.76) than 85.83% of its industry peers.
A Quick Ratio of 2.76 indicates that TR1 has no problem at all paying its short term obligations.
TR1 has a Quick ratio of 2.76. This is amongst the best in the industry. TR1 outperforms 85.83% of its industry peers.
Industry RankSector Rank
Current Ratio 2.76
Quick Ratio 2.76
TR1.DE Yearly Current Assets VS Current LiabilitesTR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.26% over the past year.
TR1 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.42% yearly.
The Revenue has been growing slightly by 4.26% in the past year.
The Revenue has been growing slightly by 4.78% on average over the past years.
EPS 1Y (TTM)5.26%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%9.34%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%6.04%

3.2 Future

Based on estimates for the next years, TR1 will show a small growth in Earnings Per Share. The EPS will grow by 4.23% on average per year.
Based on estimates for the next years, TR1 will show a small growth in Revenue. The Revenue will grow by 1.47% on average per year.
EPS Next Y3.56%
EPS Next 2Y5.37%
EPS Next 3Y4.1%
EPS Next 5Y4.23%
Revenue Next Year2.47%
Revenue Next 2Y4.35%
Revenue Next 3Y3.47%
Revenue Next 5Y1.47%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TR1.DE Yearly Revenue VS EstimatesTR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
TR1.DE Yearly EPS VS EstimatesTR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.67 indicates a reasonable valuation of TR1.
Based on the Price/Earnings ratio, TR1 is valued cheaper than 81.67% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.65. TR1 is valued rather cheaply when compared to this.
TR1 is valuated reasonably with a Price/Forward Earnings ratio of 9.68.
Based on the Price/Forward Earnings ratio, TR1 is valued cheaply inside the industry as 89.17% of the companies are valued more expensively.
TR1's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.45.
Industry RankSector Rank
PE 10.67
Fwd PE 9.68
TR1.DE Price Earnings VS Forward Price EarningsTR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TR1 indicates a rather cheap valuation: TR1 is cheaper than 82.50% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, TR1 is valued a bit cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.83
EV/EBITDA 6.96
TR1.DE Per share dataTR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TR1 does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of TR1 may justify a higher PE ratio.
PEG (NY)3
PEG (5Y)4.41
EPS Next 2Y5.37%
EPS Next 3Y4.1%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.22%, TR1 is a good candidate for dividend investing.
TR1's Dividend Yield is rather good when compared to the industry average which is at 5.42. TR1 pays more dividend than 84.17% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, TR1 pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.22%

5.2 History

On average, the dividend of TR1 grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years2
Div Non Decr Years2
TR1.DE Yearly Dividends per shareTR1.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

56.29% of the earnings are spent on dividend by TR1. This is a bit on the high side, but may be sustainable.
The dividend of TR1 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP56.29%
EPS Next 2Y5.37%
EPS Next 3Y4.1%
TR1.DE Yearly Income VS Free CF VS DividendTR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
TR1.DE Dividend Payout.TR1.DE Dividend Payout, showing the Payout Ratio.TR1.DE Dividend Payout.PayoutRetained Earnings

T ROWE PRICE GROUP INC

FRA:TR1 (11/24/2025, 7:00:00 PM)

86.84

+0.65 (+0.75%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)02-03 2026-02-03/amc
Inst Owners80.56%
Inst Owner ChangeN/A
Ins Owners1.67%
Ins Owner ChangeN/A
Market Cap19.08B
Revenue(TTM)7.21B
Net Income(TTM)2.03B
Analysts50
Price Target97.24 (11.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.22%
Yearly Dividend4.41
Dividend Growth(5Y)10.37%
DP56.29%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.28%
Min EPS beat(2)2.88%
Max EPS beat(2)9.67%
EPS beat(4)3
Avg EPS beat(4)2.48%
Min EPS beat(4)-5.31%
Max EPS beat(4)9.67%
EPS beat(8)6
Avg EPS beat(8)4.37%
EPS beat(12)10
Avg EPS beat(12)5.89%
EPS beat(16)11
Avg EPS beat(16)2.82%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-2.2%
Max Revenue beat(2)-1.12%
Revenue beat(4)0
Avg Revenue beat(4)-2.66%
Min Revenue beat(4)-4.33%
Max Revenue beat(4)-1.12%
Revenue beat(8)1
Avg Revenue beat(8)-2.88%
Revenue beat(12)2
Avg Revenue beat(12)-2.22%
Revenue beat(16)3
Avg Revenue beat(16)-2.74%
PT rev (1m)7.17%
PT rev (3m)7.78%
EPS NQ rev (1m)1.38%
EPS NQ rev (3m)7.54%
EPS NY rev (1m)0.87%
EPS NY rev (3m)3.2%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)4.51%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 10.67
Fwd PE 9.68
P/S 3.06
P/FCF 18.83
P/OCF 14.78
P/B 2.04
P/tB 2.8
EV/EBITDA 6.96
EPS(TTM)8.14
EY9.37%
EPS(NY)8.97
Fwd EY10.33%
FCF(TTM)4.61
FCFY5.31%
OCF(TTM)5.88
OCFY6.77%
SpS28.41
BVpS42.64
TBVpS31.06
PEG (NY)3
PEG (5Y)4.41
Graham Number88.37
Profitability
Industry RankSector Rank
ROA 13.79%
ROE 18.78%
ROCE 18.12%
ROIC 13.51%
ROICexc 18.68%
ROICexgc 30.26%
OM 32.91%
PM (TTM) 28.18%
GM N/A
FCFM 16.23%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
ROICexc(3y)18.71%
ROICexc(5y)21.89%
ROICexgc(3y)30.22%
ROICexgc(5y)33.06%
ROCE(3y)20.58%
ROCE(5y)24.24%
ROICexgc growth 3Y-16.2%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-13.37%
ROICexc growth 5Y-6.73%
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA 0.01
Cap/Depr 118.97%
Cap/Sales 4.45%
Interest Coverage 250
Cash Conversion 56.43%
Profit Quality 57.6%
Current Ratio 2.76
Quick Ratio 2.76
Altman-Z 5.66
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)130.91%
Cap/Depr(5y)124.54%
Cap/Sales(3y)4.8%
Cap/Sales(5y)4.19%
Profit Quality(3y)84.47%
Profit Quality(5y)86.86%
High Growth Momentum
Growth
EPS 1Y (TTM)5.26%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%9.34%
EPS Next Y3.56%
EPS Next 2Y5.37%
EPS Next 3Y4.1%
EPS Next 5Y4.23%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%6.04%
Revenue Next Year2.47%
Revenue Next 2Y4.35%
Revenue Next 3Y3.47%
Revenue Next 5Y1.47%
EBIT growth 1Y7.98%
EBIT growth 3Y-13.78%
EBIT growth 5Y-0.07%
EBIT Next Year2.03%
EBIT Next 3Y3.55%
EBIT Next 5Y0.98%
FCF growth 1Y22.49%
FCF growth 3Y-26.76%
FCF growth 5Y-0.86%
OCF growth 1Y20.05%
OCF growth 3Y-21.25%
OCF growth 5Y2.05%

T ROWE PRICE GROUP INC / TR1.DE FAQ

Can you provide the ChartMill fundamental rating for T ROWE PRICE GROUP INC?

ChartMill assigns a fundamental rating of 7 / 10 to TR1.DE.


Can you provide the valuation status for T ROWE PRICE GROUP INC?

ChartMill assigns a valuation rating of 7 / 10 to T ROWE PRICE GROUP INC (TR1.DE). This can be considered as Undervalued.


Can you provide the profitability details for T ROWE PRICE GROUP INC?

T ROWE PRICE GROUP INC (TR1.DE) has a profitability rating of 6 / 10.


What is the financial health of T ROWE PRICE GROUP INC (TR1.DE) stock?

The financial health rating of T ROWE PRICE GROUP INC (TR1.DE) is 9 / 10.


Can you provide the expected EPS growth for TR1 stock?

The Earnings per Share (EPS) of T ROWE PRICE GROUP INC (TR1.DE) is expected to grow by 3.56% in the next year.